ARHGEF12 and cancer: Increased activity of arginases could limit L-arg availability to NOS—could it be responsible for vascular abnormalities frequently described in tumorsxx Altogether, increasing evidence indicates that arginases become potentially important targets for therapeutic interventions that might improve the efficacy of immunotherapy, decrease infectious complications and improve quality of life of cancer patients.